Maverick Life Sciences - Redefining The Future of Medicine.Through cutting-edge technology and groundbreaking research, we strive to develop and implement innovative medical solutions that help push the boundaries of what’s possible.Our mission is to revolutionize healthcare by combining advanced biotechnology and next-generation treatments. From pioneering new pharmaceuticals to enhancing patient care with intelligent diagnostics, we are committed to creating a healthier future.By bridging science and technology, Maverick Life Sciences is shaping the next era of medical innovation—because the future of healthcare starts today.

Dr. Mathias Michiels is a passionate physician with broad international experience and a strong interest in medical innovation and longevity. He completed his medical degree in Belgium and specialized in family medicine. As part of his training, he gained hands-on experience through clinical placements in South Africa and London, where he developed a deep appreciation for diverse healthcare systems and patient populations.Driven by a fascination with the human body's potential and performance, Dr. Michiels pursued a Master’s degree in Sports Medicine. His career later took him to New Zealand, where he further expanded his medical expertise while working in a dynamic and multidisciplinary setting.Today, Dr. Michiels is particularly focused on preventive care, healthy aging, and exploring innovative approaches to help people live longer, healthier lives. Combining clinical knowledge with a forward-thinking mindset, he is committed to shaping the future of healthcare through both science and technology.

Prof. Dr. Sébastien Anguille is a dedicated hematologist with a strong academic background and a deep commitment to patient-centered innovation. He earned his medical degree and PhD in Belgium, and went on to specialize in hematology. His clinical and scientific journey has been marked by a focus on complex blood cancers such as leukemia and multiple myeloma.As head of the Cell Therapy and Regenerative Medicine Center at Antwerp University Hospital, he has pioneered advanced treatments including CAR-T cell therapy. His work bridges clinical excellence and translational research, aiming to accelerate access to life-saving therapies for patients.Today, Prof. Anguille is especially focused on the future of immunotherapy, integrating cutting-edge science with compassionate care. He remains driven by a vision to improve patient outcomes through innovation, collaboration, and a deep sense of medical responsibility